Skip to main content
NTLA logo

NTLA · Intellia Therapeutics, Inc.

Track NTLA — free
$12.74 +0.06 (+0.47%) At close · Sep 4
Market Cap
$1.78B
Shares
140.13M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 75 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1652130 CUSIP 45826J105 13F (30d) 245 filings 233 filers Visit website Investor relations